| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.balaxipharma.in | |
| Market Cap | 634.61 Cr. | |
| Enterprise Value(EV) | 653.34 Cr. | 2023-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -4.73 | Trailing Twelve Months Ending 2023-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
| Industry PE | 40.73 | Trailing Twelve Months Ending 2023-12 |
| Book Value / Share | 179.38 | Trailing Twelve Months Ending 2023-12 |
| Price to Book Value | 3.20 | Calculated using Price: 574.75 |
| Dividend Yield | 0.00 | Period Ending 2023-03 |
| No. of Shares Subscribed | 1.10 Cr. | 11,041,500 Shares |
| FaceValue | 10 | |
| About Balaxi Pharmaceuticals Ltd. | ||
| The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG products | ||
| 1 Day |
|
-0.87% |
| 1 Week |
|
+1.39% |
| 1 Month |
|
+21.22% |
| 3 Month |
|
+33.14% |
| 6 Month |
|
+30.67% |
| 1 Year |
|
+3.94% |
| 2 Year |
|
+33.93% |
| 5 Year |
|
+707.80% |
| 10 Year |
|
| 5 years | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
| Return on Equity (%) | 55.84 | 39.04 | 82.26 | 53.5 | 32.17 | |
| Return on Capital Employed (%) | 69.35 | 56.56 | 92.56 | 59.62 | 37.46 | |
| Return on Assets (%) | 32.19 | 29.01 | 56.23 | 34.52 | 22.09 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
| Shh. Funds | 4 | 28 | 65 | 113 | 183 | 155 | |
| Non Curr. Liab. | 0 | 0 | 4 | 3 | |||
| Curr. Liab. | 3 | 8 | 35 | 63 | 53 | 56 | |
| Minority Int. | |||||||
| Equity & Liab. | 6 | 36 | 100 | 176 | 240 | 214 | |
| Non Curr. Assets | 0 | 1 | 6 | 35 | 46 | 51 | |
| Curr. Assets | 6 | 35 | 94 | 141 | 194 | 163 | |
| Misc. Exp. not W/O | |||||||
| Total Assets | 6 | 36 | 100 | 176 | 240 | 214 |
| Particulars | 6 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
| Net Sales | 14 | 46 | 231 | 279 | 336 | 262 | |
| Other Income | 1 | 1 | 2 | 5 | 3 | -1 | |
| Total Income | 14 | 46 | 234 | 284 | 339 | 261 | |
| Total Expenditure | -12 | -37 | -189 | -229 | -279 | -216 | |
| PBIDT | 2 | 9 | 45 | 56 | 60 | 45 | |
| Interest | 0 | 0 | -1 | -1 | -1 | ||
| Depreciation | 0 | 0 | -1 | -2 | -3 | ||
| Taxation | 0 | -3 | -6 | -7 | -11 | -7 | |
| Exceptional Items | -39 | ||||||
| PAT | 2 | 6 | 38 | 48 | 46 | -5 | |
| Minority Interest | |||||||
| Share Associate | |||||||
| Other Related Items | 0 | -1 | 1 | 6 | |||
| Consolidated Net Profit | 2 | 6 | 37 | 48 | 52 | -5 | |
| Adjusted EPS | 6 | 6 | 37 | 48 | 51 | -5 |
| Particulars | 5 years | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
| Cash Fr. Operatn. | -2 | -14 | 34 | 6 | ||
| Cash Fr. Inv. | 0 | 0 | -6 | -28 | -11 | |
| Cash Fr. Finan. | 18 | 4 | 0 | 26 | ||
| Net Change | -2 | 4 | -2 | 6 | 21 | |
| Cash & Cash Eqvt | 0 | 4 | 2 | 7 | 28 |
|
Thu, 18 Apr 2024
Disclosure under SEBI Takeover Regulations BALAXI PHARMACEUTICALS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
Wed, 17 Apr 2024
Shareholders meeting BALAXI PHARMACEUTICALS LIMITED has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results. |
|
Tue, 16 Apr 2024
Disclosure under SEBI Takeover Regulations BALAXI Overseas Pvtￂﾠ LIMITEDￂﾠhas Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of Indiaￂﾠ(Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
| Fri, 19 Apr 2024 |
Opening at High
|
High Increase in 1 Month
|
High Increase in 3 Months
|
High Increase in 6 Months
|
High Increase in 5 Years
|
